MINSK, 23 November (BelTA) – The development of the country's pharmaceutical industry is taking on new significance now, Chief Academic Secretary of the National Academy of Sciences of Belarus Vasily Gursky said at the opening of the international conference Belarusian Medicines on 23 November. The event is taking place at the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, BelTA has learned.
“Today our country, our science and manufacturing are facing a very serious task, which is import substitution. This task was prompted by developments in the global economy,” said Vasily Gursky. “The established supply chains are exposed to risks or are simply disrupted. Therefore, the promotion of the country's own pharmaceutical industry, the development of domestic medicines are becoming increasingly relevant and vital. This is why such conferences are becoming more important,” the academician added.
Speaking with journalists on the sidelines of the conference, the chief academic secretary of the National Academy of Sciences noted that the task of large-scale import substitution was set by the head of state. “The National Academy of Sciences is paying much attention to import substitution. Almost all of our efforts are aimed at developing our own science-intensive products. This conference is a showcase event for our scientific achievements. Our research outputs include, in particular, antitumor medicines, other drugs,” the scientist said.
Vasily Gursky noted that the National Academy of Sciences of Belarus, which is the country's scientific hub, operates like a research and production corporation. It sets a task, develops an idea, conducts research and implements a project.
The conference will be running through 25 November. It has brought together scientists and experts from Belarus and Russia, as well as representatives of healthcare facilities and pharmaceutical companies of the country. The program includes presentations, sessions and reports, an exhibition of products of domestic manufacturers.
Participants will discuss topical issues in pharmaceutical production, biochemical pharmacology and pharmaceutical chemistry, production technologies for finished dosage forms, modern methods for analyzing biologically active substances, etc.
